Urinary Incontinence Market Expansion Can Rely on Advanced Treatment

Pune, India, July, 2023/MRFR Press Release/- Market Research Future (MRFR) has published a cooked research report on the “Global Urinary Incontinence Market” that contains information from 2023 to 2032.

key Highlights on Urinary Incontinence Market

Global Urinary Incontinence Market is accounted to register a CAGR of 6.2% during the forecast period and is estimated to reach USD 18.1 billion by 2032.

Urinary incontinence refers to the involuntary loss of bladder control, leading to the unintentional leakage of urine. It is a common condition that can affect individuals of all ages, but it is more prevalent among older adults, especially women. There are different types of urinary incontinence, including stress incontinence (leakage during activities that exert pressure on the bladder), urge incontinence (sudden and intense urge to urinate), overflow incontinence (incomplete bladder emptying resulting in constant or frequent dribbling), functional incontinence (inability to reach the bathroom in time due to physical or cognitive limitations), and mixed incontinence (a combination of different types). The causes of urinary incontinence can vary, such as weakened pelvic floor muscles, hormonal changes, nerve damage, infections, medications, obesity, pregnancy, prostate issues in men, and certain medical conditions. Treatment options include lifestyle modifications, exercises, bladder training, medication, and in some cases, surgical interventions, tailored to the specific type and underlying cause of urinary incontinence.

Key Players

MRFR recognizes the following companies as the key players in the Global Urinary Incontinence Market— NeoTract Inc, Promedon Cook Medical Inc, R. Bard Inc, Coloplast Corp, Boston Scientific Corporation, and Ethicon US LLC.

Segment Analysis

The Global Urinary Incontinence Market has been segmented based on Type, Devices.

Based on Type, the market is segmented into Urge incontinence, Stress Incontinence, Overflow incontinence, and Functional incontinence. The Urge incontinence category dominates the Urinary Incontinence market due to its high prevalence, significant impact on daily life, and the demand for effective management and treatment options for sudden and intense urges to urinate.

Based on Devices, the market is segmented into Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, and Urethral Bulking Agents. The Electrical Stimulation Devices category dominates the Urinary Incontinence market due to its effectiveness in strengthening pelvic floor muscles and improving bladder control, providing a non-invasive and targeted approach to managing and treating urinary incontinence.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Urinary Incontinence Market Research Report

Regional Analysis

The Global Urinary Incontinence Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Global Urinary Incontinence Market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The Global Urinary Incontinence Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World's Global Urinary Incontinence Market comprises of Middle East, Africa, and Latin America.

In 2022, the North America Urinary Incontinence market reached a value of USD 5.198 billion, with a market share of approximately 45.80%. It is projected to exhibit a significant compound annual growth rate (CAGR) during the study period. The increased prevalence of specific disorders such as bladder blockage, urinary incontinence (UI), benign prostate hyperplasia (BPH), urine retention, and bladder cancer is a key factor driving the regional market. Overactive bladder (OAB) and urinary urgency are frequently experienced by adults aged 40 and older, as reported by the National Association for Continence.

The Europe Urinary Incontinence market holds the second-largest market share. The urinary incontinence sling market accounted for the majority of the market value in Europe. The market for urinary incontinence slings offers both male and female slings, but it is declining as more people become aware of the risks associated with female urinary incontinence slings.

The Asia Pacific Urinary Incontinence market is expected to grow at the fastest CAGR from 2022 to 2030. The rising incidence of spinal cord injury, benign prostate hyperplasia (BPH), and urinary tract infections (UTI) drive the regional market. UTI is the most common infectious disease in the region, imposing a significant financial cost on society and linked to high morbidity and mortality rates, particularly in hospitals.

Key Findings of the Study

• The Global Urinary Incontinence Market is expected to reach USD 18.1 billion by 2032, at a CAGR of 6.2% during the forecast period.


• North America region dominates the urinary incontinence market. The increased prevalence of specific disorders such as bladder blockage, urinary incontinence (UI), benign prostate hyperplasia (BPH), urine retention, and bladder cancer drives the regional market.


• Based on the Type, the Market has been segmented into Urge incontinence holding the largest market in 2023.


• NeoTract Inc, Promedon Cook Medical Inc, R. Bard Inc, Coloplast Corp, Boston Scientific Corporation, Ethicon US LLC.